Impel Neuropharma Inc reports results for the quarter ended in March - Earnings Summary

IPI Legacy Liquidation Co

07/06/2021 13:53

* Impel Neuropharma Inc  IMPL.OQ  reported a quarterly adjusted
loss of 54 cents​​ per share for the quarter ended in March. The
mean expectation of two analysts for the quarter was for a loss
of 93 cents per share.
* Reported revenue was zero​;  analysts expected zero. 
* Impel Neuropharma Inc's reported EPS for the quarter was a
loss of $15.09​.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* The company reported a quarterly loss of $11.42 million.
* Wall Street's median 12-month price target for Impel
Neuropharma Inc is $32.00 
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 3 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
This summary was machine generated June 7 at 12:52 p.m. GMT.
​All figures in US dollars